Lincotek Acquires Majority Stake in Danco Medical

Global contract manufacturer Lincotek announced the completion of the acquisition of a majority stake in Danco Medical from Danco Anodizing, strengthening the group's Medical Division. The transaction scope encompasses all service operations focused on metal surface finishing for the medical market and includes the ISO-13485 certified facility in Warsaw, Indiana, USA. Operating since 1971 in California and 2001 in Indiana, Danco Medical provides medical orthopedic device companies with comprehensive, single-source surface preparation and finishing solutions and a wide range of product identification methods. It is also a leader in aluminum and titanium anodizing and offers ChemFilm, electropolishing, passivation processes and low-friction chrome plating services. The latest innovative developments include unique deep-image graphics for cases and trays and HANano surface processing.

Integrated solutions

Lincotek Medical provides orthopedic device companies with fully integrated supply chain solutions including device engineering, casting, forging, additive manufacturing, precision machining, plasma spray, calcium phosphate and physical vapor deposition coatings, as well as electrochemical processes and final packaging. This acquisition will expand Lincotek's comprehensive capabilities in the medical field and increase the company's manufacturing footprint by one facility (approximately 35,000 square feet with 150 employees), providing the company with greater competitive advantage on a diverse range of projects. Lincotek Group CEO Winfried Schaller said, "This is a perfect match between two companies," and added "We can now offer a 360-degree service around all possible needs of the global orthopedic device industry. We believe this creates a unique platform for the sector addressing the fundamental need for supply chain simplification and reduced lead times. We will be able to efficiently provide all supply chain steps from a single source." Danco is recognized for its ability to meet quality requirements, meet short delivery dates and maintain detailed records for long-term traceability. The company will remain an independent unit within the Lincotek Medical structure. The former owners and management will continue to operate the company as before to ensure quality and service levels are maintained. Danco Medical CEO Ross Tiamson said, "With Danco Medical's joining Lincotek Group, we will strengthen our growth strategies by creating a fully integrated portfolio that supports our customer needs and expectations. Our well-established company values are on the right track. Danco Medical looks forward to this new era with anticipation."